Literature DB >> 31076508

Functional characterization of a subtilisin-like serine protease from Vibrio cholerae.

Matthew Howell1,2, Daniel G Dumitrescu1,2,3, Lauren R Blankenship1,2, Darby Herkert1,2, Stavroula K Hatzios4,2,3.   

Abstract

Vibrio cholerae, the causative agent of the human diarrheal disease cholera, exports numerous enzymes that facilitate its adaptation to both intestinal and aquatic niches. These secreted enzymes can mediate nutrient acquisition, biofilm assembly, and V. cholerae interactions with its host. We recently identified a V. cholerae-secreted serine protease, IvaP, that is active in V. cholerae-infected rabbits and human choleric stool. IvaP alters the activity of several host and pathogen enzymes in the gut and, along with other secreted V. cholerae proteases, decreases binding of intelectin, an intestinal carbohydrate-binding protein, to V. cholerae in vivo IvaP bears homology to subtilisin-like enzymes, a large family of serine proteases primarily comprised of secreted endopeptidases. Following secretion, IvaP is cleaved at least three times to yield a truncated enzyme with serine hydrolase activity, yet little is known about the mechanism of extracellular maturation. Here, we show that IvaP maturation requires a series of sequential N- and C-terminal cleavage events congruent with the enzyme's mosaic protein domain structure. Using a catalytically inactive reporter protein, we determined that IvaP can be partially processed in trans, but intramolecular proteolysis is most likely required to generate the mature enzyme. Unlike many other subtilisin-like enzymes, the IvaP cleavage pattern is consistent with stepwise processing of the N-terminal propeptide, which could temporarily inhibit, and be cleaved by, the purified enzyme. Furthermore, IvaP was able to cleave purified intelectin, which inhibited intelectin binding to V. cholerae These results suggest that IvaP plays a role in modulating intelectin-V. cholerae interactions.
© 2019 Howell et al.

Entities:  

Keywords:  bacteria; cholera; host-pathogen interaction; intelectin; lectin; pathogenesis; serine protease; subtilisin

Mesh:

Substances:

Year:  2019        PMID: 31076508      PMCID: PMC6597830          DOI: 10.1074/jbc.RA119.007745

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  40 in total

1.  In situ proteolysis of the Vibrio cholerae matrix protein RbmA promotes biofilm recruitment.

Authors:  Daniel R Smith; Manuel Maestre-Reyna; Gloria Lee; Harry Gerard; Andrew H-J Wang; Paula I Watnick
Journal:  Proc Natl Acad Sci U S A       Date:  2015-08-03       Impact factor: 11.205

2.  Human intelectin is a novel soluble lectin that recognizes galactofuranose in carbohydrate chains of bacterial cell wall.

Authors:  S Tsuji; J Uehori; M Matsumoto; Y Suzuki; A Matsuhisa; K Toyoshima; T Seya
Journal:  J Biol Chem       Date:  2001-04-19       Impact factor: 5.157

3.  Genetic Determinants of Penicillin Tolerance in Vibrio cholerae.

Authors:  Anna I Weaver; Shannon G Murphy; Benjamin D Umans; Srikar Tallavajhala; Ikenna Onyekwere; Stephen Wittels; Jung-Ho Shin; Michael VanNieuwenhze; Matthew K Waldor; Tobias Dörr
Journal:  Antimicrob Agents Chemother       Date:  2018-09-24       Impact factor: 5.191

4.  RNA-Seq-based monitoring of infection-linked changes in Vibrio cholerae gene expression.

Authors:  Anjali Mandlik; Jonathan Livny; William P Robins; Jennifer M Ritchie; John J Mekalanos; Matthew K Waldor
Journal:  Cell Host Microbe       Date:  2011-08-18       Impact factor: 21.023

5.  Proteomic analysis of the Vibrio cholerae type II secretome reveals new proteins, including three related serine proteases.

Authors:  Aleksandra E Sikora; Ryszard A Zielke; Daniel A Lawrence; Philip C Andrews; Maria Sandkvist
Journal:  J Biol Chem       Date:  2011-03-08       Impact factor: 5.157

6.  Growth in a biofilm induces a hyperinfectious phenotype in Vibrio cholerae.

Authors:  Rita Tamayo; Bharathi Patimalla; Andrew Camilli
Journal:  Infect Immun       Date:  2010-06-01       Impact factor: 3.441

7.  Subtilisin-like serine protease from hyperthermophilic archaeon Thermococcus kodakaraensis with N- and C-terminal propeptides.

Authors:  T Foophow; S Tanaka; Y Koga; K Takano; S Kanaya
Journal:  Protein Eng Des Sel       Date:  2010-01-25       Impact factor: 1.650

8.  RpoS controls the Vibrio cholerae mucosal escape response.

Authors:  Alex Toftgaard Nielsen; Nadia A Dolganov; Glen Otto; Michael C Miller; Cheng Yen Wu; Gary K Schoolnik
Journal:  PLoS Pathog       Date:  2006-10       Impact factor: 6.823

9.  Studies of dynamic protein-protein interactions in bacteria using Renilla luciferase complementation are undermined by nonspecific enzyme inhibition.

Authors:  Stavroula K Hatzios; Simon Ringgaard; Brigid M Davis; Matthew K Waldor
Journal:  PLoS One       Date:  2012-08-15       Impact factor: 3.240

10.  Genomic insights into the 2016-2017 cholera epidemic in Yemen.

Authors:  François-Xavier Weill; Daryl Domman; Nicholas R Thomson; Marie-Laure Quilici; Elisabeth Njamkepo; Abdullrahman A Almesbahi; Mona Naji; Samar Saeed Nasher; Ankur Rakesh; Abdullah M Assiri; Naresh Chand Sharma; Samuel Kariuki; Mohammad Reza Pourshafie; Jean Rauzier; Abdinasir Abubakar; Jane Y Carter; Joseph F Wamala; Caroline Seguin; Christiane Bouchier; Thérèse Malliavin; Bita Bakhshi; Hayder H N Abulmaali; Dhirendra Kumar; Samuel M Njoroge; Mamunur Rahman Malik; John Kiiru; Francisco J Luquero; Andrew S Azman; Thandavarayan Ramamurthy
Journal:  Nature       Date:  2019-01-02       Impact factor: 49.962

View more
  2 in total

1.  Gene Silencing through CRISPR Interference in Mycoplasmas.

Authors:  Daria V Evsyutina; Gleb Y Fisunov; Olga V Pobeguts; Sergey I Kovalchuk; Vadim M Govorun
Journal:  Microorganisms       Date:  2022-06-05

2.  Maturation of subtilisin-like protease NbSLP1 from microsporidia Nosema bombycis.

Authors:  Rong Wang; Qingyan Li; Fangyan Liu; Xiaoqun Dang; Quan Sun; Xiaotian Sheng; Mingyu Hu; Jialing Bao; Jie Chen; Guoqing Pan; Zeyang Zhou
Journal:  Front Cell Infect Microbiol       Date:  2022-08-15       Impact factor: 6.073

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.